Circular RNA screening from EIF3a in lung cancer

• Main Authors: Ma‐Sha Huang, Fu‐Qiang Yuan, Yang Gao, Jun‐Yan Liu, Yi‐Xin Chen, Chen‐Jing Wang, Bai‐Mei He, Hong‐Hao Zhou, Zhao‐Qian Liu
• Format: Article
• Language: English
• Published: Wiley 2019-08-01
• Series: Cancer Medicine
• Subjects: bioinformatics; circular RNA; EIF3a; lung cancer
• Online Access: https://doi.org/10.1002/cam4.2338

Abstract Eukaryotic initiation factor 3 (EIF3) is one of the largest and most complex translation initiation factors, which consists of 13 subunits named eukaryotic translation initiation factor 3 subunit A (EIF3a) to EIF3m. EIF3a is the largest subunit of EIF3. Previous studies suggested that EIF3a is a housekeeping gene, recent results have found that EIF3a is closely related to the tumorigenesis and drug resistance. Circular RNAs (circRNAs) derived from biologically important gene can play an important role in gene regulation. However, the mechanism underlying circRNAs’ biological functions is not well understood yet. In this work, we screened 31 EIF3a‐derived circRNAs, in which two circEIF3as were identified to be correlated with cisplatin drug sensitivity in lung cancer. Two circEIF3as were found involved in RNA‐binding proteins‐mediated biological processes and may be related to translational regulation according to bioinformatics analyses. CircEIF3as, the transcriptional initiation factor EIF3a transcribed circRNAs, are associated with both drug sensitivity and translation regulation. These findings mean that they may have a functional synergy effect with EIF3a or be valuable therapeutic targets for treatment like EIF3a. This is the first study that exploits circRNAs screening from EIF3a in lung cancer, our findings provide a novel perspective on the function of EIF3a and circEIF3as in lung cancer.